ExodusPoint Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
ExodusPoint Capital Management's IONS Position: Q3 2026 in Review
ExodusPoint Capital Management increased its Ionis Pharmaceuticals (IONS) stake by 584% in Q3 2026, buying an estimated $11.8M and bringing the position to 243,687 shares worth $10.9M. The position accounts for 0.06% of the portfolio, ranked #321.
ExodusPoint Capital Management first reported a position in IONS in Q4 2018 and has held it in 20 quarters since. The position peaked at $17.1M in Q1 2026. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- ExodusPoint Capital Management held 243,687 shares of Ionis Pharmaceuticals worth $10.9M as of Q3 2026.
- ExodusPoint Capital Management bought 208,042 Ionis Pharmaceuticals shares in Q3 2026, an estimated $11.8M.
- Ionis Pharmaceuticals made up 0.06% of ExodusPoint Capital Management's portfolio in Q3 2026, its #321 holding.
- ExodusPoint Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2018 and has held it in 20 quarters since.
- ExodusPoint Capital Management's Ionis Pharmaceuticals position peaked at $17.1M in Q1 2026.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.